Moderna and Merck’s Melanoma Vaccine Breakthrough | Charlottesville News

Charlottesville News Today | 2 Min News | The Daily News Now! · Aug 20, 2026 · 1m

Moderna and Merck just dropped groundbreaking data on a personalized mRNA vaccine for melanoma that slashes the risk of recurrence or spread—offering real hope for patients who’ve already beaten the disease. This isn’t early-stage hype; it’s late-stage results showing the power of tailoring treatments to each person’s unique tumor, training the immune system to hunt down lingering cancer cells. It’s a major leap forward in precision medicine, turning the tide on one of cancer’s most feared relapses—and hinting at a future where treatments are as individualized as the diseases they fight…